Eliciting and stop dose during oral food challenges for peanut and common tree nuts in different age groups

Wouter W de Weger1, Diede Jansen1, Lidy van Lente2

  • 1Department of Paediatrics, Martini Hospital, Groningen, The Netherlands.

PubMed

Insights

Oral food challenges (OFCs) can be inconclusive in young children. To avoid false negatives, the full cumulative dose should be consumed, especially in uneventful food allergy testing.

Area of Science:

  • Allergy and Immunology
  • Pediatric Gastroenterology
  • Clinical Trials

Background:

  • Oral food challenges (OFCs) are standard for diagnosing food allergies.
  • Younger children may not consume sufficient doses, leading to inconclusive results.
  • Inconclusive OFCs can cause diagnostic uncertainty and anxiety.

Purpose of the Study:

  • To assess the eliciting dose for objective symptoms across age groups.
  • To determine if the final dose is necessary in uneventful OFCs.
  • To minimize false negative outcomes in food allergy diagnosis.

Main Methods:

  • Retrospective analysis of 1327 OFCs for common allergens (2012-2019).
  • Examined age as a predictor of the stop dose in inconclusive OFCs.
  • Assessed the association of age with eliciting dose and potential false negatives.

Main Results:

  • 224 (16.9%) OFCs were inconclusive; age predicted stop dose only for almond.
  • Objective symptoms occurred after the final dose in 2%-13% of positive OFCs.
  • Potential false negatives were identified in 27.6% of uneventful OFCs.

Conclusions:

  • Children under 6 often consume all doses in negative OFCs.
  • Eliciting dose for symptoms is not age-dependent.
  • A cumulative dose of 4.4g is recommended in uneventful OFCs to prevent false negatives.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...